Viatris (1VTRS) Stock Forecast & Price Target

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

1VTRS Analyst Ratings

Moderate Buy

5 Buy

3 Hold

1 Sell

Based on 9 analysts giving stock ratings to

Viatris

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

1VTRS Stock 12 Month Forecast

Average Price Target

€17.61

▲(20.28% Upside)

Based on 9 Wall Street analysts offering 12 month price targets for Viatris in the last 3 months. The average price target is €17.61 with a high forecast of €23.15 and a low forecast of €11.57. The average price target represents a 20.28% change from the last price of €14.64.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"€7","24":"€24","11.25":"€11.25","15.5":"€15.5","19.75":"€19.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":23.14961142,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€23.15</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":17.60953347333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€17.61</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":11.57480571,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€11.57</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,11.25,15.5,19.75,24],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.67,16.245354724615385,16.82070944923077,17.396064173846153,17.97141889846154,18.546773623076923,19.122128347692307,19.69748307230769,20.272837796923078,20.84819252153846,21.423547246153845,21.998901970769232,22.574256695384616,{"y":23.14961142,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.67,15.819194882564101,15.968389765128205,16.117584647692308,16.266779530256407,16.41597441282051,16.565169295384614,16.714364177948717,16.863559060512817,17.01275394307692,17.161948825641023,17.311143708205126,17.460338590769226,{"y":17.60953347333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,15.67,15.354985054615385,15.039970109230769,14.724955163846154,14.40994021846154,14.094925273076923,13.779910327692308,13.464895382307692,13.149880436923077,12.834865491538462,12.519850546153846,12.204835600769231,11.889820655384614,{"y":11.57480571,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.362,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":8.704,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 2,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.981,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":10.384,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 5,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.151,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.485,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.583,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 8,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":12.7,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":13.578,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.104,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.106,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.37,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.67,"date":1790812800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 6,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€23.15

Average Price Target€17.61

Lowest Price Target€11.57

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Ashwani Verma

UBS

€20.48→€23.15

Buy

58.13%

Upside

Reiterated

10/05/26

Viatris price target raised to $26 from $23 at UBSViatris price target raised to $26 from $23 at UBS

Les Sulewski

Oppenheimer

€22.26

Buy

52.04%

Upside

Initiated

09/23/26

Viatris initiated with an Outperform at OppenheimerViatris initiated with an Outperform at Oppenheimer

David Amsellem

Piper Sandler

€10.68→€11.57

Hold

-20.94%

Downside

Reiterated

09/16/26

Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS) and Vera Therapeutics (NASDAQ: VERA)

Daniel Clark

Leerink Partners

€17.81

Buy

21.64%

Upside

Initiated

09/09/26

Leerink sees growth for Viatris, starts at OutperformLeerink sees growth for Viatris, starts at Outperform

Jasper Hellweg

Argus Research

€13.36→€17.81

Buy

21.64%

Upside

Reiterated

09/08/26

Viatris price target raised to $20 from $15 at ArgusViatris price target raised to $20 from $15 at Argus

Glen Santangelo

Barclays

€19.59

Buy

33.80%

Upside

Reiterated

08/17/26

Barclays Keeps Their Buy Rating on Viatris (VTRS)

Chris Schott

J.P. Morgan

€16.03

Hold

9.47%

Upside

Reiterated

08/10/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Orthofix Medical (NASDAQ: OFIX), Rhythm Pharmaceuticals (NASDAQ: RYTM) and Viatris (NASDAQ: VTRS)

Salveen Richter

Goldman Sachs

€16.03→€17.81

Hold

21.64%

Upside

Reiterated

08/06/26

Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS), Immunocore Holdings (NASDAQ: IMCR) and Praxis Precision Medicines (NASDAQ: PRAX)

Jason Gerberry

Bank of America Securities

€12.47

Sell

-14.86%

Downside

Reiterated

07/10/26

Bank of America Securities Keeps Their Sell Rating on Viatris (VTRS)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€15.14

Buy

3.39%

Upside

Reiterated

03/20/26

Jefferies Keeps Their Buy Rating on Viatris (VTRS)

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Ashwani Verma

UBS

€20.48→€23.15

Buy

58.13%

Upside

Reiterated

10/05/26

Viatris price target raised to $26 from $23 at UBSViatris price target raised to $26 from $23 at UBS

Les Sulewski

Oppenheimer

€22.26

Buy

52.04%

Upside

Initiated

09/23/26

Viatris initiated with an Outperform at OppenheimerViatris initiated with an Outperform at Oppenheimer

David Amsellem

Piper Sandler

€10.68→€11.57

Hold

-20.94%

Downside

Reiterated

09/16/26

Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS) and Vera Therapeutics (NASDAQ: VERA)

Daniel Clark

Leerink Partners

€17.81

Buy

21.64%

Upside

Initiated

09/09/26

Leerink sees growth for Viatris, starts at OutperformLeerink sees growth for Viatris, starts at Outperform

Jasper Hellweg

Argus Research

€13.36→€17.81

Buy

21.64%

Upside

Reiterated

09/08/26

Viatris price target raised to $20 from $15 at ArgusViatris price target raised to $20 from $15 at Argus

Glen Santangelo

Barclays

€19.59

Buy

33.80%

Upside

Reiterated

08/17/26

Barclays Keeps Their Buy Rating on Viatris (VTRS)

Chris Schott

J.P. Morgan

€16.03

Hold

9.47%

Upside

Reiterated

08/10/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Orthofix Medical (NASDAQ: OFIX), Rhythm Pharmaceuticals (NASDAQ: RYTM) and Viatris (NASDAQ: VTRS)

Salveen Richter

Goldman Sachs

€16.03→€17.81

Hold

21.64%

Upside

Reiterated

08/06/26

Analysts Offer Insights on Healthcare Companies: Viatris (NASDAQ: VTRS), Immunocore Holdings (NASDAQ: IMCR) and Praxis Precision Medicines (NASDAQ: PRAX)

Jason Gerberry

Bank of America Securities

€12.47

Sell

-14.86%

Downside

Reiterated

07/10/26

Bank of America Securities Keeps Their Sell Rating on Viatris (VTRS)

Unknown Analyst

Jefferies

Not Ranked

Jefferies

€15.14

Buy

3.39%

Upside

Reiterated

03/20/26

Jefferies Keeps Their Buy Rating on Viatris (VTRS)

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

KURAKura Oncology

DNLIDenali Therapeutics

OVIDOvid Therapeutics

HITIHigh Tide

AXGNAxoGen

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Viatris

3 Months

Les SulewskiOppenheimer

Success Rate

8/8 ratings generated profit

Average Return

+20.60%

Copying Les Sulewski's trades and holding each position for 3 Months would result in 100.00% of your transactions generating a profit, with an average return of +20.60% per trade.

1 Year

Les SulewskiOppenheimer

Success Rate

8/8 ratings generated profit

Average Return

+44.79%

Copying Les Sulewski's trades and holding each position for 1 Year would result in 100.00% of your transactions generating a profit, with an average return of +44.79% per trade.

2 Years

Les SulewskiOppenheimer

Success Rate

8/8 ratings generated profit

Average Return

+44.79%

Copying Les Sulewski's trades and holding each position for 2 Years would result in 100.00% of your transactions generating a profit, with an average return of +44.79% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

1VTRS Analyst Recommendation Trends

Rating

Jun 26

Jul 26

Aug 26

Sep 26

Oct 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 1VTRS has received 6 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. 1VTRS average Analyst price target in the past 3 months is 17.61.

Each month's total comprises the sum of three months' worth of ratings.

1VTRS Financial Forecast

1VTRS Earnings Forecast

Next quarter’s earnings estimate for 1VTRS is €0.57 with a range of €0.55 to €0.61. The previous quarter’s EPS was €0.61. 1VTRS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 1VTRS has Performed in-line its overall industry.

1VTRS Sales Forecast

Next quarter’s sales forecast for 1VTRS is €3.38B with a range of €3.33B to €3.44B. The previous quarter’s sales results were €3.35B. 1VTRS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 1VTRS has Performed in-line its overall industry.

1VTRS Stock Forecast FAQ

What is IT:1VTRS’s average 12-month price target, according to analysts?

Based on analyst ratings, Viatris’s 12-month average price target is 17.61.

What is IT:1VTRS’s upside potential, based on the analysts’ average price target?

Viatris has 20.28% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Viatris a Buy, Sell or Hold?

Viatris has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 3 hold ratings and 1 sell ratings.

What is Viatris’s share price target?

The average share price target for Viatris is 17.61. This is based on 9 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €23.15 ,and the lowest forecast is €11.57. The average share price target represents 20.28% Increase from the current price of €14.64.

What do analysts say about Viatris?

Viatris’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 9 Wall Streets Analysts.

How can I buy shares of Viatris?

To buy shares of IT:1VTRS, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Viatris (1VTRS) Stock Forecast & Price Target

1VTRS Analyst Ratings

1VTRS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Viatris

1VTRS Analyst Recommendation Trends

1VTRS Financial Forecast

1VTRS Earnings Forecast

1VTRS Sales Forecast

1VTRS Stock Forecast FAQ

Detailed List of Analyst Forecasts